Christopher Jenkins

611 total citations
11 papers, 455 citations indexed

About

Christopher Jenkins is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Christopher Jenkins has authored 11 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Christopher Jenkins's work include Acute Lymphoblastic Leukemia research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Christopher Jenkins is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Acute Myeloid Leukemia Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Christopher Jenkins collaborates with scholars based in United Kingdom, Canada and United States. Christopher Jenkins's co-authors include Andrew P. Weng, Jay Gunawardana, King Tan, Bruce W. Woolcock, Laurie H. Sehn, Ryan D. Morin, Christian Steidl, Marco A. Marra, Randy D. Gascoyne and Sanja Rogić and has published in prestigious journals such as Nature Medicine, Blood and British Journal of Haematology.

In The Last Decade

Christopher Jenkins

10 papers receiving 447 citations

Peers

Christopher Jenkins

ONCOL

MB

PFM

GENET

IMMUN

Yoshitomo Maesako Japan

Susan Eckerle Germany

Neil Palmisiano United States

Guillem Clot Spain

Brian L. Abbott United States

Bertrand Nadel France

Danielle Shafer United States

Ángel Ramírez Páyer Spain

Daniela Hoehn United States

Raúl Gabus Uruguay

Yoshitomo Maesako Japan

Christopher Jenkins

115 ×0.6

ONCOL

105 ×0.6

MB

173 ×1.1

PFM

117 ×1.1

GENET

97 ×1.1

IMMUN

Citations per year, relative to Christopher Jenkins Christopher Jenkins (= 1×) peers Yoshitomo Maesako

Countries citing papers authored by Christopher Jenkins

Since Specialization

Citations

This map shows the geographic impact of Christopher Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Jenkins more than expected).

Fields of papers citing papers by Christopher Jenkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Jenkins. The network helps show where Christopher Jenkins may publish in the future.

Co-authorship network of co-authors of Christopher Jenkins

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Jenkins. A scholar is included among the top collaborators of Christopher Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Jenkins. Christopher Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Hayes, Martin A., et al.. (2021). P-177 Exploration of attendance across 28 ECHO Project ECHO networks in the context of everyday practice. Poster presentations. A73.1–A73. 1 indexed citations

2.

Giambra, Vincenzo, Christopher Jenkins, Hongfang Wang, et al.. (2012). NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-θ and reactive oxygen species. Nature Medicine. 18(11). 1693–1698. 68 indexed citations

3.

Jenkins, Christopher, Hongfang Wang, Olena O Shevchuk, et al.. (2012). Collaboration Between RUNX and NOTCH Pathways in T-Cell Acute Lymphoblastic Leukemia. Blood. 120(21). 1279–1279. 2 indexed citations

4.

Lee, Kit Ming, Clive S. McKimmie, Derek S. Gilchrist, et al.. (2011). D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood. 118(23). 6220–6229. 69 indexed citations

5.

Kridel, Robert, Barbara Meissner, Sanja Rogić, et al.. (2011). Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 119(9). 1963–1971. 241 indexed citations

6.

Jenkins, Christopher, Saman Hewamana, David Krige, Chris Pepper, & Alan Burnett. (2010). Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia. Leukemia Research. 35(5). 677–681. 16 indexed citations

7.

Giambra, Vincenzo, Oksana Nemirovsky, Sonya H.L. Lam, et al.. (2010). Notch-Mediated Suppression of PKCθ Reduces Reactive Oxygen Species and Promotes Leukemic Stem Cell Activity In T-Cell Acute Lymphoblastic Leukemia (T-ALL). Blood. 116(21). 12–12. 3 indexed citations

8.

Jenkins, Christopher, Saman Hewamana, Amanda Gilkes, et al.. (2008). Nuclear factor‐κB as a potential therapeutic target for the novel cytotoxic agent LC‐1 in acute myeloid leukaemia. British Journal of Haematology. 143(5). 661–671. 20 indexed citations

9.

Jenkins, Christopher, Ken Mills, Chris Pepper, & Alan Burnett. (2007). Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.. Blood. 110(11). 1608–1608. 5 indexed citations

10.

Jenkins, Christopher, et al.. (1989). Developing a breast cancer screening program for Chinese-American women.. PubMed. 16(2). 181–7. 28 indexed citations

11.

Jenkins, Christopher, et al.. (1987). Breast cancer facts: a look at mammography.. PubMed. 48(10). 507–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact